Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
7
×
eli lilly
7
×
fda
7
×
indiana blog main
life sciences
national blog main
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
seattle blog main
startups
7
×
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana top stories
national
national top stories
new york top stories
raleigh-durham top stories
san diego top stories
san francisco top stories
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
deals
bristol-myers squibb
investing
abbvie
alzheimer's disease
amgen
astrazeneca
cancer immunotherapy
What
bio
roundup
alzheimer’s
black
companies
diabetes
diamond’s
drug
growing
week
alliance
annual
appetite
approved
assessed
attention
beta
bionics
biotech
blood
bread
bristol
butter
buy
buyout
calls
cancer
cash
changing
closed
color
communities
conference
congress
continue
crispr
days
debut
democrats
developing
Language
unset
Current search:
fda
×
" clinical trials "
×
" eli lilly "
×
startups
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
